Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema.
作者信息
Kutlu Ali, Karabacak Ercan, Aydın Ersin, Akarsu Selim, Öztürk Sami
机构信息
Department of Allergy and Immunology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
Department of Dermatology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.
出版信息
Ann Dermatol. 2016 Jun;28(3):381-2. doi: 10.5021/ad.2016.28.3.381. Epub 2016 May 25.
Abstract
摘要
相似文献
1
Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary Angioedema.
Ann Dermatol. 2016 Jun;28(3):381-2. doi: 10.5021/ad.2016.28.3.381. Epub 2016 May 25.
2
Chronic spontaneous urticaria and angioedema requiring treatment with omalizumab in a patient with hereditary angioedema.
Ann Allergy Asthma Immunol. 2019 Jun;122(6):666-667. doi: 10.1016/j.anai.2019.02.019. Epub 2019 Mar 1.
3
Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1056-1063. doi: 10.1111/jdv.14075. Epub 2017 Jan 17.
4
Efficacy of Treatment of Non-hereditary Angioedema.
Clin Rev Allergy Immunol. 2018 Jun;54(3):412-431. doi: 10.1007/s12016-016-8585-0.
5
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.
Ann Allergy Asthma Immunol. 2016 Oct;117(4):370-377.e1. doi: 10.1016/j.anai.2016.06.024. Epub 2016 Jul 14.
6
Angioedema is an unfavorable factor for the response to omalizumab in chronic spontaneous urticaria: A retrospective study.
Dermatol Ther. 2019 Jan;32(1):e12752. doi: 10.1111/dth.12752. Epub 2018 Oct 30.
7
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.
Allergy. 2016 Aug;71(8):1135-44. doi: 10.1111/all.12870. Epub 2016 Mar 31.
8
Idiopathic Non-histaminergic Angioedema: Successful Treatment with Omalizumab in Five Patients.
J Clin Immunol. 2017 Jan;37(1):80-84. doi: 10.1007/s10875-016-0345-7. Epub 2016 Nov 8.
9
Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials.
Clin Transl Allergy. 2017 Aug 31;7:27. doi: 10.1186/s13601-017-0164-9. eCollection 2017.
10
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients.
Case Reports Immunol. 2018 Jul 22;2018:8067610. doi: 10.1155/2018/8067610. eCollection 2018.
本文引用的文献
1
Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab.
J Dtsch Dermatol Ges. 2013 Jul;11(7):677-8. doi: 10.1111/ddg.12075. Epub 2013 Apr 10.
2
Long-term efficacy of fixed-dose omalizumab for patients with severe chronic spontaneous urticaria.
Ann Allergy Asthma Immunol. 2013 Feb;110(2):113-7. doi: 10.1016/j.anai.2012.11.022. Epub 2012 Dec 20.
3
Omalizumab in chronic urticaria.
Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):406-11. doi: 10.1097/ACI.0b013e328355365a.
4
Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.
J Allergy Clin Immunol. 2006 Jun;117(6):1493-9. doi: 10.1016/j.jaci.2006.02.028. Epub 2006 Apr 27.
5
Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11.
BMC Immunol. 2002 Jun 12;3:5. doi: 10.1186/1471-2172-3-5.
Zotero 插件